Δ9-tetrahydrocannabinol, a cannabis sativa–derived natural product, as a probe of endocannabinoid system plasticity in type 1 diabetes: a receptor-level, testable hypothesis
Type 1 diabetes (T1D) is a chronic autoimmune disease in which receptor-level regulation of the endocannabinoid system (ECS) remains largely unmapped. While ECS perturbations have been extensively described in obesity and type 2 diabetes, a directed experimental interrogation of receptor adaptabilit...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-07-01
|
| Col·lecció: | Frontiers in Natural Products |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fntpr.2026.1812441/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|